Ocugen Inc
Research Ocugen Inc (OCGN) on Bullrun: market cap USD 474.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOCGN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 474.66M
- Financial periodQ2 2026
- RevenueUSD 1.49M
- Net income-USD 24.88M
- Free cash flow-USD 12.22M
Valuation Snapshot
latest market cap is USD 474.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 4.41M | -USD 68.00M | -USD 57.15M | n/a | -0.22 | USD 18.89M | USD 28.79M | -USD 12.17M |
| FY2024 | USD 4.06M | -USD 54.00M | -USD 45.53M | n/a | -0.2 | USD 58.82M | USD 28.67M | USD 29.63M |
| FY2023 | USD 6.04M | -USD 63.00M | -USD 72.53M | n/a | -0.26 | USD 39.46M | USD 2.80M | USD 40.56M |
| FY2022 | USD 2.49M | -USD 86.80M | -USD 64.54M | n/a | -0.4 | USD 77.56M | USD 2.29M | USD 73.98M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 474.66M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 421.71M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 236.01M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 146.21M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 284.55M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 907.18M | n/a | n/a | n/a |
About Ocugen Inc
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ocugen Inc's market cap?
Ocugen Inc's market capitalization is USD 474.66M.
What does Ocugen Inc do?
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health.